Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.

[1]  Takashi Morita,et al.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.

[2]  H. Verberne,et al.  Cardiac 123I-MIBG scintigraphy in heart failure. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[3]  R. Hetzer,et al.  Prediction of Cardiac Stability After Weaning From Left Ventricular Assist Devices in Patients With Idiopathic Dilated Cardiomyopathy , 2008, Circulation.

[4]  M. Nakazawa,et al.  Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction , 2008, Journal of Nuclear Medicine.

[5]  L. Brewster,et al.  Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.

[6]  Jeroen J. Bax,et al.  Cardiac neuronal imaging: Application in the evaluation of cardiac disease , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[7]  W. Burchert,et al.  I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Stavros G Drakos,et al.  Reverse remodeling during long-term mechanical unloading of the left ventricle. , 2007, Journal of molecular and cellular cardiology.

[9]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[10]  S. Drakos,et al.  Ventricular-assist devices for the treatment of chronic heart failure , 2007, Expert review of cardiovascular therapy.

[11]  M. Kurabayashi,et al.  Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. , 2007, European heart journal.

[12]  Magdi H Yacoub,et al.  Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.

[13]  M. Anastasiou-Nana,et al.  Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 2005, The American journal of cardiology.

[14]  T. Myers,et al.  Left Ventricular Unloading with an Assist Device Results in Receptor Relocalization as well as Increased Beta‐Adrenergic Receptor Numbers: Are These Changes Indications for Outcome? , 2005, Journal of cardiac surgery.

[15]  M. Kurabayashi,et al.  Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. , 2005, Journal of the American College of Cardiology.

[16]  M. Komeda,et al.  Heterotopic Transplantation of the Failing Rat Heart as a Model of Left Ventricular Mechanical Unloading Toward Recovery , 2005, ASAIO journal.

[17]  笠間 周.  Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy , 2004 .

[18]  M. Kurabayashi,et al.  Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy , 2003 .

[19]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[20]  H. Matsuda,et al.  Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  N. Smedira,et al.  Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.

[22]  M. Yacoub.  A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. , 2001, European heart journal.

[23]  M. Oz,et al.  Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  H. Figulla,et al.  Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  S. Houser,et al.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. , 1998, Circulation.

[26]  Q. Li,et al.  Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. , 1998, The Journal of clinical investigation.

[27]  W. Mitsuoka,et al.  Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. , 1995, Journal of the American College of Cardiology.

[28]  P. Merlet,et al.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  N. Shibata,et al.  Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Y. Yazaki,et al.  Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation. , 1991, The Journal of biological chemistry.

[31]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[32]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. , 1990, The American journal of cardiology.

[33]  R. Spielmann,et al.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. , 1988, Journal of the American College of Cardiology.